Ovarian Cancer Coverage from Every Angle
Editor:
Ursula A. Matulonis, MD
Advertisement
Advertisement

Ongoing CE Activities

Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer
Expert Insights: Addressing Critical Questions in the Evolving Management of Ovarian Cancer (login required)
Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer
Investigator Perspectives on the Current and Future Management of Newly Diagnosed Ovarian Cancer
Maintenance Therapy for Ovarian Cancer: Practical Considerations for Community Practice
Consensus or Controversy: Management of initial relapse of ovarian cancer — Eight investigators weigh in on their current approach based on genomic profiling
Novel Agents and Emerging Strategies in the Management of Gynecologic Cancers
Oncology Grand Rounds: PARP Inhibitors in Ovarian Cancer
Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Ovarian Cancer
Beyond the Guidelines: Investigator Perspectives on the Current and Future Role of PARP Inhibition in the Management of Ovarian Cancer
Selecting Cancer Treatment: The Role of Tumor Molecular Profiling and Liquid Biopsy
Second Opinion: New and Emerging Treatment Strategies in the Management of Recurrent Ovarian Cancer
The Emerging Role of Molecular Testing in an Era of Precision Medicine - Ovarian Cancer
Data + Perspectives: Biologic Basis and Available Clinical Research Underlying the Protocol and Nonresearch Use of PARP Inhibition in Patients with Ovarian and Breast Cancer
Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers
Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.